Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
06/2004
06/22/2004US6753127 Using mixture of norbornene polymer, acid generator and solvent; prebaking, exposure to radiation
06/17/2004WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116515 Novel fluorinated and alkylated dibenzylidene alditol derivatives
06/17/2004US20040116483 Glucagon antagonists/inverse agonists
06/17/2004US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
06/17/2004US20040116428 Biguanide and dihydrotriazine derivatives
06/17/2004US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
06/17/2004US20040115836 Novel dioxin analogues and methods and kits for searching out dioxins-decomposing organisms or emzymes or dioxin-decoposing enzyme genes
06/17/2004US20040115732 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
06/16/2004EP1428817A1 ACID AMIDE DERIVATIVES, PROCESS FOR PRODUCING THESE, AND PEST CONTROL AGENT CONTAINING THESE
06/16/2004CN1505540A Reactor for gas/liquid or gas/liquid/solid reactions
06/16/2004CN1504458A Ketal intermediate obtained from preparation of trion-bis(oxime ether) derivatives
06/16/2004CN1153769C Purine derivatives, intermediates and preparing process thereof
06/16/2004CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds
06/10/2004WO2004048329A1 Antitumor benzoylsulfonamides
06/10/2004WO2004048320A1 Biguanide and dihydrotriazine derivatives
06/10/2004US20040110967 Novel fluorinated and alkylated dibenzylidene alditol derivatives
06/09/2004EP1426370A1 Propanolamine derivative having 1,4 benzodioxane ring
06/09/2004EP1426046A1 Novel use of tricyclic compound
06/09/2004EP0994868B1 Method for preparing optically active 5-methyl-2- (1-methyl-butyl)-5-propyl-1,3-dioxan
06/09/2004CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
06/08/2004US6747031 N-heterocyclic derivatives as NOS inhibitors
06/03/2004WO2004046105A2 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
06/03/2004WO2004046074A1 Method of preparing di(ketene acetals)
06/03/2004US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
06/03/2004US20040106611 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004CA2506041A1 Method of preparing di(ketene acetals)
06/02/2004EP1423365A1 Process for the preparation of indole derivatives
06/02/2004EP1423357A2 Urea derivatives with antiproteolytic activity
06/02/2004CN1501923A Glycolide production process, and glycolic acid oligomer for glycolide production
06/01/2004US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
05/2004
05/27/2004US20040101476 Method and device for manufacturing zeolite from ashes resulting from the incineration of combustible waste
05/27/2004DE19628519B4 Verfahren zur Herstellung von 1,4-Dioxan-2,5-dionen, Piperazoniumsalze von α-Hydroxycarbonsäuren und deren Verwendung A process for preparing 1,4-dioxane-2,5-diones, Piperazoniumsalze of α-hydroxycarboxylic acids and their use
05/26/2004EP1422213A1 Process for producing optically active halopropanediol derivative
05/26/2004EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
05/26/2004EP1322315A4 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
05/26/2004EP0915819B1 Illudin analogs useful as antitumor agents
05/21/2004WO2004041787A1 Process for producing quinolinecarbaldehyde
05/21/2004WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/21/2004CA2505239A1 Process for producing quinolinecarbaldehyde
05/21/2004CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/20/2004US20040097742 Method of preparing di(ketene acetals)
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
05/19/2004EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts
05/19/2004DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/13/2004WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor
05/13/2004WO2004039768A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
05/13/2004US20040092753 Method for producing unsaturated cyclic ethers
05/13/2004DE10348173A1 New cyclohexane derivatives are useful as components in liquid crystal media having a low rotation viscosity, high clear point, high dielectric anisotropy and high specific resistance
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines
05/12/2004EP1097128B1 Imidamide derivatives
05/12/2004EP1026143B1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element
05/12/2004EP1024139B1 Process for the preparation of optically active 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid derivatives
05/12/2004CN1496359A Glycolide production process and glycolic acid composition
05/12/2004CN1496281A Improved method for producing unsaturated cyclic ethers
05/11/2004US6734238 Radiation transparent; antiperspirant gel
05/06/2004WO2004037807A2 Medicinal arylethanolamine compounds
05/06/2004WO2004037806A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
05/06/2004WO2004037773A1 Phenethanolamine derivative for the treatment of respiratory diseases
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087805 Glycolide production process, and glycolic acid composition
05/06/2004EP1415987A1 Nitrogenous aromatic ring compounds
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/06/2004EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide
05/06/2004EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
05/06/2004CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases
05/06/2004CA2503452A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
05/05/2004CN1494539A Antagonists of MCP-1 function and methods of use thereof
05/05/2004CN1493570A Process for preparing
05/05/2004CN1148366C Formaldehyde acrolactic ester etherified glycerine acetal and its synthesis process
05/04/2004US6730815 Etherification reaction of glycol with monohydric alcohol in presence of polyperfluorosulfonic acid resin catalyst
05/04/2004US6730803 Production method of a beta -keto ester compound of claim 1, which comprises condensation of a 2-cyano-2,2-dimethylacetate solution to give 2-cyano-2,2- dimethylacetate of the formula (ii), and condensation thereof
05/04/2004US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
04/2004
04/29/2004US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
04/29/2004US20040082812 Using amide of a triiodobenzene compound as chemical intermediate
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments
04/29/2004US20040082625 Osteoporosis, bone disorders
04/28/2004EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/28/2004EP1412323A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof
04/28/2004EP1412322A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
04/28/2004CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
04/28/2004CN1147459C Galcium receptor-active compound
04/28/2004CN1147294C Pentafluorobenzenesulfonamides and analogs
04/22/2004WO2004032630A1 Agent for controlling protist and/or harmful substance comprising fired product of shell powder
04/22/2004WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004US20040077502 Stable ethylene inhibiting compounds and methods for their preparation
04/22/2004DE10197218T5 Neue Dioxin-Analoga, Verfahren und Kits zum Screening nach Organismen oder Enzymen, die zum Abbau von Dioxinen in der Lage sind, oder Genen, die ein zum Abbau von Dioxinen befähigtes Enzym codieren New dioxin analogs, methods and kits for screening for organisms or enzymes for the degradation of dioxins in a position or genes that encode an enzyme for degradation of dioxins UNTRAINED
04/21/2004EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1408976A1 Treatment for attention-deficit hyperactivity disorder
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/20/2004US6723866 High clearing point and low rotational viscosity; phenylisothiocyanates
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 103